Recursion Pharmaceuticals (RXRX) just delivered encouraging Phase 1b/2 TUPELO data for its FAP drug candidate REC-4881, and that clinical update has quickly reshaped how both Wall Street and ...
Abstract: Nowadays, as the demand for accurate object detection (OD) applications is increasing, several attempts have been made to introduce convolutional neural network (CNN)-based super-resolution ...
Abstract: This paper focuses on the phase-noise (PN) and channel estimation for mmWave massive MIMO systems with hybrid analog-digital structures. By considering the PN caused by the impairment of ...
The following slide deck was published by Recursion Pharmaceuticals, Inc. in conjunction with this event.
Hi, everyone, and welcome. I'm Najat Khan, Recursion's Chief R&D and Chief Commercial Officer and incoming CEO and President. Let's jump right in. Today is an important moment for Recursion, for our ...
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...
Enzyme lets you precisely locate and transform data deep within Elixir data structures using an intuitive path syntax. Rather than manually traversing nested maps and lists, you can extract or modify ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback